Nuclear Movement LINC Complex and Emery-Dreifuss Muscular Dystrophy

核运动 LINC 复合体和 Emery-Dreifuss 肌营养不良症

基本信息

  • 批准号:
    9341898
  • 负责人:
  • 金额:
    $ 43.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-01 至 2020-08-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Emery-Dreifuss muscular dystrophy (EDMD) is caused by mutations in genes encoding proteins of the nuclear envelope. Autosomal EDMD results from mutations in LMNA, which encodes A-type lamins, and X-linked EDMD from mutations in EMD, which encodes emerin. Mutations in genes encoding nesprins and SUNs are also associated with the EDMD phenotype. Nesprins and SUNs comprise the linker of the nucleoskeleton and cytoskeleton (LINC) complex that spans the nuclear membranes. The LINC complex connects the nuclear lamina, which binds to SUNs, to cytoskeletal components including actin, which bind to nesprins. Emerin also associates with lamins and nesprins and modifies LINC complex function. Alterations in expression or primary structure of the nuclear envelope proteins implicated in EDMD prevent the proper movement and positioning of nuclei in migrating cells. In parallel, there is an activation in signaling by the MAP kinase ERK1/2, which itself blocks nuclear movement. This has lead us to hypothesize that all of the nuclear envelope "EDMD proteins" contribute to a common cellular pathway that controls nuclear positioning, which is essential for proper skeletal muscle structure and directed migration of myogenic progenitors. We propose to test this hypothesis by examining links between nuclear movement, ERK1/2 activity, nuclear positioning in skeletal muscle, muscle progenitor cell migration and EDMD pathogenesis in three specific aims. Aim 1 will involve a series of cell biological experiments designed to uncover how hyperactivated ERK1/2 prevents nuclear movement, including investigation of a previously uncharacterized hypothetical brake. In Aim 2, we will determine how nuclear movement affects ERK1/2 activation by dissecting its relationship to ERK1/2 activity during physiological activation of the kinase and then testing if moving the nucleus is necessary and sufficient to regulate ERK1/2 signaling. In Aim 3, we will first determine if EDMD-associated protein alterations that block nuclear movement interfere with myoblast fusion and differentiation in vitro. We will then use mouse models of EDMD to investigate the role A-type lamins and emerin on nuclear movement in regenerating skeletal muscle and to determine if alterations in these proteins block migration of myogenic progenitors into injured muscle. We will also determine if reducing ERK1/2 activity, which is elevated in skeletal muscle in EDMD, has effects on these processes. Overall, the proposed research will provide novel insights into the cellular pathology of EDMD, a poorly understood muscular dystrophy, and simultaneously uncover new information about nuclear movement, a process of broad significance to basic cell biology.
 描述(由申请人提供):Emery-Dreifuss肌营养不良症(EDMD)是由编码核膜蛋白的基因突变引起的。常染色体EDMD由编码A型核纤层蛋白的LMNA突变引起,X连锁EDMD由编码Emerin的EMD突变引起。编码nesprins和SUN的基因突变也与EDMD表型相关。Nesprins和SUN包含跨越核膜的核骨架和细胞骨架(LINC)复合物的接头。LINC复合物将与SUN结合的核纤层连接到细胞骨架组分,包括与nesprins结合的肌动蛋白。Emerin还与核纤层蛋白和nesprins结合并修饰LINC复合体功能。与EDMD有关的核膜蛋白的表达或一级结构的改变阻止了迁移细胞中细胞核的正确运动和定位。与此同时,MAP激酶ERK 1/2激活了信号传导,其本身阻断了核运动。这使我们假设所有的核膜“EDMD蛋白”都有助于控制核定位的共同细胞途径,这对于适当的骨骼肌结构和肌源性祖细胞的定向迁移是必不可少的。我们建议通过检查核运动,ERK 1/2活性,核定位在骨骼肌,肌肉祖细胞迁移和EDMD发病机制在三个特定的目标之间的联系来测试这一假设。目标1将涉及一系列旨在揭示过度激活的ERK 1/2如何阻止核运动的细胞生物学实验,包括对以前未表征的假设制动的研究。在目标2中,我们将确定细胞核运动如何影响ERK 1/2激活,通过解剖其与ERK 1/2活性在激酶的生理激活过程中的关系,然后测试是否移动细胞核是必要的和足够的调节ERK 1/2信号。在目标3中,我们将首先确定是否EDMD相关蛋白的改变,阻止核运动干扰成肌细胞融合和分化在体外。然后,我们将使用EDMD小鼠模型,研究A型核纤层蛋白和emerin在再生骨骼肌中对核运动的作用,并确定这些蛋白质的改变是否会阻止肌源性祖细胞迁移到受伤的肌肉中。我们还将确定降低EDMD骨骼肌中升高的ERK 1/2活性是否对这些过程产生影响。总的来说,拟议的研究将为EDMD的细胞病理学提供新的见解,EDMD是一种知之甚少的肌营养不良症,同时揭示有关核运动的新信息,这是一个对基础细胞生物学具有广泛意义的过程。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gregg G Gundersen其他文献

Gregg G Gundersen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gregg G Gundersen', 18)}}的其他基金

Mechanistic Basis of Cardiac Laminopathy
心脏核纤层病的机制基础
  • 批准号:
    10650433
  • 财政年份:
    2021
  • 资助金额:
    $ 43.16万
  • 项目类别:
Mechanistic Basis of Cardiac Laminopathy
心脏核纤层病的机制基础
  • 批准号:
    10279393
  • 财政年份:
    2021
  • 资助金额:
    $ 43.16万
  • 项目类别:
Cytoskeleton, Nucleus and Integrin Recycling in Cell Migration
细胞迁移中的细胞骨架、细胞核和整合素回收
  • 批准号:
    10396505
  • 财政年份:
    2020
  • 资助金额:
    $ 43.16万
  • 项目类别:
Cytoskeleton, Nucleus and Integrin Recycling in Cell Migration
细胞迁移中的细胞骨架、细胞核和整合素回收
  • 批准号:
    10613943
  • 财政年份:
    2020
  • 资助金额:
    $ 43.16万
  • 项目类别:
Cytoskeleton, Nucleus and Integrin Recycling in Cell Migration
细胞迁移中的细胞骨架、细胞核和整合素回收
  • 批准号:
    10799051
  • 财政年份:
    2020
  • 资助金额:
    $ 43.16万
  • 项目类别:
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging
衰老过程中的核骨架-细胞骨架连接和细胞极性
  • 批准号:
    10289402
  • 财政年份:
    2019
  • 资助金额:
    $ 43.16万
  • 项目类别:
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging
衰老过程中的核骨架-细胞骨架连接和细胞极性
  • 批准号:
    9982166
  • 财政年份:
    2019
  • 资助金额:
    $ 43.16万
  • 项目类别:
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging
衰老过程中的核骨架-细胞骨架连接和细胞极性
  • 批准号:
    10153650
  • 财政年份:
    2019
  • 资助金额:
    $ 43.16万
  • 项目类别:
Nucleoskeleton-Cytoskeleton Connections and Cell Polarity in Aging
衰老过程中的核骨架-细胞骨架连接和细胞极性
  • 批准号:
    10394870
  • 财政年份:
    2019
  • 资助金额:
    $ 43.16万
  • 项目类别:
Integrin Recycling and Adhesion Formation in Cell Migration
细胞迁移中整合素的回收和粘附形成
  • 批准号:
    9765849
  • 财政年份:
    2019
  • 资助金额:
    $ 43.16万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.16万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 43.16万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.16万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.16万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.16万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.16万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.16万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 43.16万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 43.16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 43.16万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了